Robert J. Smith, MD
NPI 1477594901ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Providence, RI
Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Providence, Rhode Island, licensed in RI, with an NPI issued in June 2006. Astrazeneca Pharmaceuticals LP reported $4,119 in payments in 2025, mostly consulting fees.
Overview
| NPI | 1477594901 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Jun 8, 2006 |
| Last updated in NPPES | Nov 15, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | MD10539 | RI |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|
Industry payments (Open Payments)
- 2025$4,119 · 1 payment from 1 company
- 2024$11,009 · 1 payment from 1 company
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,119 | 1 |
What the 2025 payments were for
- Consulting Fee$4,119 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Providence
- 1407954415
- 1346442563
- 1598863599
- 1942946223
- 1427635465
- 1154389120
- 1518911783
- 1437823275
- 1407995640
- 1699122010
- 1841381555
- 1780641084
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Rhode Island →